Sidan 40 - U.S. Tillväxt Aktier

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPPDATERAD Jul 10, 2026

Upptäck U.S. Tillväxtaktier som är noterade på NYSE och NASDAQ. Sorterade efter prognostiserad tillväxt har dessa stocks högre vinst- eller försäljningstillväxt än förväntat jämfört med andra företag.

5,197 Företag

Företag	Senaste pris	7D Återkomst	1 års avkastning	Marknadsvärde	Analytikernas mål	Värdering	Tillväxt	Avkastning på aktier	Industri
CHPT	US$5.99	0.5%	-54.7%	US$149.7m	US$6.58	-0.8	51.0%	n/a	Capital Goods
ROIV	US$35.97	2.4%	216.6%	US$26.5b	US$39.38	3132.2	50.9%	n/a	Pharmaceuticals & Biotech
MNPR	US$106.60	9.0%	189.1%	US$700.0m	US$113.62	5.3	50.9%	n/a	Pharmaceuticals & Biotech
NVCT	US$18.35	-6.2%	132.9%	US$598.7m	US$31.80	40.7	50.8%	n/a	Pharmaceuticals & Biotech
OBAI	US$0.66	-7.6%	n/a	US$16.0m	US$2.00	1.6	50.8%	n/a	Commercial Services
INR	US$12.60	0.8%	-17.4%	US$802.4m	US$23.00	5.4	50.7%	n/a	Energy
ADPT	US$21.06	-0.6%	78.2%	US$3.5b	US$20.57	11.4	50.6%	n/a	Pharmaceuticals & Biotech
VTRS	US$16.27	-2.6%	78.4%	US$19.0b	US$17.81	1.3	50.6%	3.0%	Pharmaceuticals & Biotech
MDB	US$342.08	-3.6%	68.9%	US$29.2b	US$395.52	10.6	50.5%	n/a	Software
TARA	US$4.32	6.4%	41.6%	US$236.1m	US$26.57	1.3	50.5%	n/a	Pharmaceuticals & Biotech
MTRX	US$12.49	-0.3%	-6.5%	US$358.7m	US$20.00	2.5	50.5%	n/a	Capital Goods
SNOW	US$261.45	0.5%	24.0%	US$92.7b	US$292.53	18.0	50.5%	n/a	Software
LB	US$76.69	4.0%	28.5%	US$6.0b	US$80.57	67.4	50.4%	0.6%	Real Estate Management and Development
AVBP	US$33.69	-2.8%	55.8%	US$1.6b	US$43.64	4.8	50.4%	n/a	Pharmaceuticals & Biotech
CAMT	US$143.79	0.9%	60.8%	US$6.7b	US$187.58	137.8	50.4%	0%	Semiconductors
ASTE	US$56.62	-1.6%	41.1%	US$1.3b	US$72.50	50.5	50.4%	0.9%	Capital Goods
BLFS	US$28.18	0.2%	28.4%	US$1.4b	US$32.11	13.5	50.4%	n/a	Pharmaceuticals & Biotech
CRNX	US$83.58	97.9%	161.8%	US$8.8b	US$82.50	487.7	50.4%	n/a	Pharmaceuticals & Biotech
NXGL	US$0.52	-8.3%	-80.7%	US$4.7m	US$2.00	1.2	50.3%	n/a	Healthcare
ZETA	US$21.49	3.8%	53.5%	US$5.5b	US$28.68	3.7	50.3%	n/a	Software
TITN	US$18.27	-0.4%	-8.3%	US$408.1m	US$23.00	0.7	50.3%	n/a	Capital Goods
XFOR	US$4.41	6.8%	208.4%	US$373.5m	US$11.75	46.1	50.2%	n/a	Pharmaceuticals & Biotech
PTCT	US$84.85	1.8%	74.8%	US$7.4b	US$94.14	8.5	50.2%	n/a	Pharmaceuticals & Biotech
ARBE	US$0.71	-9.1%	-54.3%	US$90.4m	US$2.50	60.4	50.2%	n/a	Tech

Page 40 of 217